Genvor Incorporated
GNVR
$1.50
-$0.20-11.77%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 122.77% | 60.27% | 86.98% | 151.08% | 97.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 130.32% | 64.88% | 86.33% | 146.19% | 93.43% |
| Operating Income | -130.32% | -64.88% | -86.33% | -146.19% | -93.43% |
| Income Before Tax | -93.73% | -53.46% | -76.72% | -126.97% | -68.97% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -93.73% | -53.46% | -76.72% | -126.97% | -68.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -93.73% | -53.46% | -76.72% | -126.97% | -68.97% |
| EBIT | -130.32% | -64.88% | -86.33% | -146.19% | -93.43% |
| EBITDA | -130.42% | -64.91% | -86.39% | -146.31% | -93.57% |
| EPS Basic | -80.63% | -40.45% | -63.33% | -110.84% | -63.43% |
| Normalized Basic EPS | -106.17% | -49.31% | -73.95% | -127.21% | -82.58% |
| EPS Diluted | -80.63% | -40.45% | -63.33% | -110.84% | -63.43% |
| Normalized Diluted EPS | -106.17% | -49.31% | -73.95% | -127.21% | -82.58% |
| Average Basic Shares Outstanding | 29.26% | 19.46% | 12.65% | 7.61% | 1.81% |
| Average Diluted Shares Outstanding | 29.26% | 19.46% | 12.65% | 7.61% | 1.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |